InsiderClue
Insiders · Profile

PAPA JOSEPH C

President and CEO at Emergent BioSolutions · Director at Candel Therapeutics · CHAIRMAN & CEO at Bausch Health Companies · and 1 more. Filing since 16 Jan 2014. CIK 0001242215

EBS Emergent BioSolutions Inc. President and CEO · 1 trade CADL Candel Therapeutics, Inc. Director · 2 trades BHC Bausch Health Companies Inc. CHAIRMAN & CEO · 5 trades PRGO PERRIGO Co plc CEO · 4 trades
Company
Date
Role
Action
Shares
Amount
Of holding
EBS Emergent BioSolutions Inc.
13 May 2025
President and CEO
Bought
60,000
$349.80K
21.2%
CADL Candel Therapeutics, Inc.
9 Dec 2022
Director
Bought
35,018
$67.93K
×12
CADL Candel Therapeutics, Inc.
8 Dec 2022
Director
Bought
3,014
$5.12K
opened
BHC Bausch Health Companies Inc.
13 Sep 2019
CHAIRMAN & CEO
Bought
30,000
$699.30K
3.7%
BHC Bausch Health Companies Inc.
28 Feb 2019
CHAIRMAN & CEO
Bought
30,000
$710.10K
4.4%
BHC Bausch Health Companies Inc.
14 Sep 2018
CHAIRMAN & CEO
Bought
30,000
$669.60K
4.8%
BHC Bausch Health Companies Inc.
13 Mar 2018
CHAIRMAN & CEO
Bought
30,000
$481.50K
4.4%
BHC Bausch Health Companies Inc.
10 Jun 2016
CHAIRMAN & CEO
Bought
202,000
$4.94M
9.0%
PRGO PERRIGO Co plc
28 Dec 2015
CEO
Sold, plan not stated
10,183
$1.50M
7.9%
PRGO PERRIGO Co plc
24 Mar 2014
President and CEO
Sold, plan not stated
10,000
$1.58M
9.5%
PRGO PERRIGO Co plc
14 Feb 2014
President and CEO
Sold, plan not stated
5,000
$752.53K
4.9%
PRGO PERRIGO Co plc
16 Jan 2014
President and CEO
Sold, plan not stated
5,000
$787.96K
4.9%
12 decisions on file.